The medial temporal lobe in dementia with lewy bodies: A comparative study with Alzheimer's disease

Annals of Neurology

Volumn 43, Issue 1, 1998, Pages 102-106

  Lippa, C F ^a   Johnson, R ^a   Smith, T W ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; FEMALE; HUMANS; LEWY BODIES; MALE; TEMPORAL LOBE;

EID: 0031936233     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430117     Document Type: Article

References (27)

1. Van Hoesen GW, Hyman BT, Damasio AR. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1991;1:1-8
2. George AE, de Leon MJ, Stylopoulos LA, et al. CT diagnostic features of Alzheimer's disease: importance of the choroidal/ hippocampal fissure complex. AJNR 1990;11:101-107
3. Jack CR, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188
4. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy. Neurology 1991;41:51-54
5. Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49:402-408
6. Rusinek H, de Leon MJ, George AE, et al. Alzheimer's disease: measuring loss of cerebral gray matter with MR imaging. Radiology 1991;178:109-114
7. Seab JP, Jagust WJ, Wong STS, et al. Quantitative NMR measurement of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8:200-208
8. Dickson DW, Ruan D, Crystal H, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DDLB) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neuntes specific to DLBD. Neurology 1991;41:1402-1409
9. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990;40:1-8
10. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type: a clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139
11. Lennox G, Lowe R, Marl R, et al. Anti-ubiquitin immunochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989;52:67-71
12. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204
13. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathologic study. Ann Neurol 1994;35:81-88
14. Lippa CF, Pulaski-Salo D, Dickson DW, Smith TW. Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci 1997;147:161-166
15. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies: report of the Consortium on Dementia with Lewy Bodies International Workshop. Neurology 1996;46:1113-1124
16. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Neurology 1991;41:479-486
17. Ball MJ. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia: a quantitative study. Acta Neuropathol (Berl) 1977;37:111-118
18. Hyman BT, Van Hoesen GW, Kromer BA, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:472-481
19. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170
20. Van Hoesen GW, Damasio AR, Hyman BT. Perforant pathway disruption and other temporal lobe pathology in Alzheimer's disease. Neurology 1985;35(Suppl):219 (Abstract)
21. Gomez-Isla T, Growdon W, McNamara M, et al. Diffuse Lewy body dementia: quantitative neuropathological studies and APOE genotyping. Neurology 1997;48(Suppl):A140 (Abstract)
22. Duvernoy HM. Anatomy of the hippocampus In: The human hippocampus. Berlin: JF Bergmann Verlag Munchen, 1988:28
23. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer's disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol 1997;56:499-508
24. Horl U, Corey-Bloom J, Hansen LA, et al. Diagnostic accuracy of dementia with Lewy bodies: a prospective study. Neurology 1997;48(Suppl):A101 (Abstract)
25. Crystal HA, Dickson DW, Lizardi JE, et al. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-1528
26. Forstl H, Burns A, Luthert P, et al. The Lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993;162:385-392
27. Ragland R, Lippa CF, Smith TW, et al. Macro and micro imaging in Alzheimer's disease: does atrophy on MRI predict neuronal loss? Neurology 1994;44(Suppl):A386 (Abstract)